Insider Transactions in Q3 2022 at Crinetics Pharmaceuticals, Inc. (CRNX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2022
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,168
-3.98%
|
$87,528
$21.01 P/Share
|
|
Sep 07
2022
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,042
-0.98%
|
$21,882
$21.0 P/Share
|
|
Sep 01
2022
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,126
-2.87%
|
$56,268
$18.59 P/Share
|
|
Jul 26
2022
|
Jeff E. Knight Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,152
-18.88%
|
$23,040
$20.7 P/Share
|
|
Jul 13
2022
|
Matthew K Fust |
SELL
Open market or private sale
|
Direct |
5,700
-31.26%
|
$114,000
$20.96 P/Share
|
|
Jul 13
2022
|
Matthew K Fust |
BUY
Exercise of conversion of derivative security
|
Direct |
5,700
+23.81%
|
$5,700
$1.45 P/Share
|